Michael Coke is a partner at Wilson Sonsini, where his practice focuses on a wide variety of corporate, securities, and related matters, primarily for life science and technology companies.
Michael's practice spans the full range of corporate transactions, including representing clients in connection with initial public offerings and other securities offerings, corporate governance and disclosure matters, mergers and acquisitions, and venture-backed private financings. He also has experience advising on secondary market transactions for institutional purchasers. Michael has worked on matters in numerous life science and technology industries, including biotechnology and life sciences, cloud computing software and services, social media and online gaming, network services and devices, data security, semiconductor, consumer products, media, public utilities, clean technology, natural resources, insurance, and finance.